{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T15:33:54Z","timestamp":1781364834898,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of genetic autosomal recessive diseases that cause severe cholestasis, which progresses to cirrhosis and liver failure, in infancy or early childhood. We herein report the clinical outcomes of surgical management in patients with four types of PFIC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Six patients diagnosed with PFIC who underwent surgical treatment between 1998 and 2020 at our institution were retrospectively assessed. Living-donor liver transplantation (LDLT) was performed in 5 patients with PFIC. The median age at LDLT was 4.8 (range: 1.9\u201311.4) years. One patient each with familial intrahepatic cholestasis 1 (FIC1) deficiency and bile salt export pump (BSEP) deficiency died after LDLT, and the four remaining patients, one each with deficiency of FIC1, BSEP, multidrug resistance protein 3 (MDR3), and tight junction protein 2 (TJP2), survived. One FIC1 deficiency recipient underwent LDLT secondary to deterioration of liver function, following infectious enteritis. Although he underwent LDLT accompanied by total external biliary diversion, the patient died because of PFIC-related complications. The other patient with FIC1 deficiency had intractable pruritus and underwent partial internal biliary diversion (PIBD) at 9.8\u00a0years of age, pruritus largely resolved after PIBD. One BSEP deficiency recipient, who had severe graft damage, experienced recurrence of cholestasis due to the development of antibodies against BSEP after LDLT, and eventually died due to graft failure. The other patient with BSEP deficiency recovered well after LDLT and there was no evidence of posttransplant recurrence of cholestasis. In contrast, recipients with MDR3 or TJP2 deficiency showed good courses and outcomes after LDLT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although LDLT was considered an effective treatment for PFIC, the clinical courses and outcomes after LDLT were still inadequate in patients with FIC1 and BSEP deficiency. LDLT accompanied by total biliary diversion may not be as effective for patients with FIC1 deficiency.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-022-01365-1","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:08:49Z","timestamp":1642054129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series"],"prefix":"10.1186","volume":"8","author":[{"given":"Kazunori","family":"Masahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tazuke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"1365_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/00005176-199402000-00003","volume":"18","author":"PF Whitington","year":"1994","unstructured":"Whitington PF, Freese DK, Alonso EM, Schwarzenberg SJ, Sharp HL. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr. 1994;18:134\u201341.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1365_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0031-1272831","volume":"31","author":"RA Morotti","year":"2011","unstructured":"Morotti RA, Suchy FJ, Magid MS. Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Semin Liver Dis. 2011;31:3\u201310.","journal-title":"Semin Liver Dis"},{"key":"1365_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/hep.21950","volume":"47","author":"CC Paulusma","year":"2008","unstructured":"Paulusma CC, Folmer DE, Ho-Mok KS, de Waart DR, Hilarius PM, Verhoeven AJ, Oude Elferink RP. ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity. Hepatology. 2008;47:268\u201378.","journal-title":"Hepatology"},{"key":"1365_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1053\/jhep.2001.27663","volume":"34","author":"P Ujhazy","year":"2001","unstructured":"Ujhazy P, Ortiz D, Misra S, Li S, Moseley J, Jones H, et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology. 2001;34:768\u201375.","journal-title":"Hepatology"},{"key":"1365_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/hep.21212","volume":"44","author":"CC Paulusma","year":"2006","unstructured":"Paulusma CC, Groen A, Kunne C, Ho-Mok KS, Spijkerboer AL, Rudi de Waart D, et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology. 2006;44:195\u2013204.","journal-title":"Hepatology"},{"key":"1365_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng0398-219","volume":"18","author":"LN Bull","year":"1998","unstructured":"Bull LN, van Eijk MJ, Pawlikowska L, DeYoung JA, Juijn JA, Liao M, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet. 1998;18:219\u201324.","journal-title":"Nat Genet"},{"key":"1365_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-2001-19034","volume":"21","author":"SW van Mil","year":"2001","unstructured":"van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin Liver Dis. 2001;21:535\u201344.","journal-title":"Semin Liver Dis"},{"key":"1365_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0168-8278(03)00286-1","volume":"39","author":"P Lykavieris","year":"2003","unstructured":"Lykavieris P, van Mil S, Cresteil D, Fabre M, Hadchouel M, Klomp L, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol. 2003;39:447\u201352.","journal-title":"J Hepatol"},{"key":"1365_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/3034","volume":"20","author":"SS Strautnieks","year":"1998","unstructured":"Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998;20:233\u20138.","journal-title":"Nat Genet"},{"key":"1365_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1055\/s-2001-19038","volume":"21","author":"R Thompson","year":"2001","unstructured":"Thompson R, Strautnieks S. BSEP: function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis. 2001;21:545\u201350.","journal-title":"Semin Liver Dis"},{"key":"1365_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/hep.510230435","volume":"23","author":"JF Deleuze","year":"1996","unstructured":"Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, et al. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology. 1996;23:904\u20138.","journal-title":"Hepatology"},{"key":"1365_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 2001;120:1448\u201358.","journal-title":"Gastroenterology"},{"key":"1365_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng.2918","volume":"46","author":"M Sambrotta","year":"2014","unstructured":"Sambrotta M, Strautnieks S, Papouli E, Rushton P, Clark BE, Parry DA, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46:326\u20138.","journal-title":"Nat Genet"},{"key":"1365_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00535-017-1423-1","volume":"53","author":"G Vitale","year":"2018","unstructured":"Vitale G, Gitto S, Raimondi F, Mattiaccio A, Mantovani V, Vukotic R, et al. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing. J Gastroenterol. 2018;53:945\u201358.","journal-title":"J Gastroenterol"},{"key":"1365_CR15","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.4103\/0366-6999.171440","volume":"128","author":"HY Wang","year":"2015","unstructured":"Wang HY, Zhao YL, Liu Q, Yuan H, Gao Y, Lan L, et al. Identification of two disease-causing genes TJP2 and GJB2 in a Chinese family with unconditional autosomal dominant nonsyndromic hereditary hearing impairment. Chin Med J (Engl). 2015;128:3345\u201351.","journal-title":"Chin Med J (Engl)"},{"key":"1365_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3748\/wjg.v26.i5.550","volume":"26","author":"CS Wei","year":"2020","unstructured":"Wei CS, Becher N, Friis JB, Ott P, Vogel I, Gr\u00f8nb\u00e6k H. New tight junction protein 2 variant causing progressive familial intrahepatic cholestasis type 4 in adults: a case report. World J Gastroenterol. 2020;26:550\u201361.","journal-title":"World J Gastroenterol"},{"key":"1365_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s00595-007-3736-9","volume":"38","author":"S Ekinci","year":"2008","unstructured":"Ekinci S, Karnak I, G\u00fcrakan F, Y\u00fcce A, Senocak ME, Cahit Tanyel F, et al. Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases. Surg Today. 2008;38:726\u201330.","journal-title":"Surg Today"},{"key":"1365_CR18","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jpedsurg.2007.03.029","volume":"42","author":"J Bustorff-Silva","year":"2007","unstructured":"Bustorff-Silva J, Sbraggia Neto L, Ol\u00edmpio H, de Alcantara RV, Matsushima E, De Tommaso AM, et al. Partial internal biliary diversion through a cholecystojejunocolonic anastomosis\u2013a novel surgical approach for patients with progressive familial intrahepatic cholestasis: a preliminary report. J Pediatr Surg. 2007;42:1337\u201340.","journal-title":"J Pediatr Surg"},{"key":"1365_CR19","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00383-014-3559-x","volume":"30","author":"P Ramachandran","year":"2014","unstructured":"Ramachandran P, Shanmugam NP, Sinani SA, Shanmugam V, Srinivas S, Sathiyasekaran M, et al. Outcome of partial internal biliary diversion for intractable pruritus in children with cholestatic liver disease. Pediatr Surg Int. 2014;30:1045\u20139.","journal-title":"Pediatr Surg Int"},{"key":"1365_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","volume":"84","author":"C Englert","year":"2007","unstructured":"Englert C, Grabhorn E, Richter A, Rogiers X, Burdelski M, Ganschow R. Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation. 2007;84:1361\u20133.","journal-title":"Transplantation"},{"key":"1365_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00268-010-0869-6","volume":"35","author":"T Hori","year":"2011","unstructured":"Hori T, Egawa H, Miyagawa-Hayashino A, Yorifuji T, Yonekawa Y, Nguyen JH, et al. Living-donor liver transplantation for progressive familial intrahepatic cholestasis. World J Surg. 2011;35:393\u2013402.","journal-title":"World J Surg"},{"key":"1365_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5500\/wjt.v6.i2.278","volume":"6","author":"A Mehl","year":"2016","unstructured":"Mehl A, Bohorquez H, Serrano MS, Galliano G, Reichman TW. Liver transplantation and the management of progressive familial intrahepatic cholestasis in children. World J Transplant. 2016;6:278\u201390.","journal-title":"World J Transplant"},{"key":"1365_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/hep.23083","volume":"50","author":"V Keitel","year":"2009","unstructured":"Keitel V, Burdelski M, Vojnisek Z, Schmitt L, H\u00e4ussinger D, Kubitz R. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis. Hepatology. 2009;50:510\u20137.","journal-title":"Hepatology"},{"key":"1365_CR24","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa0901075","volume":"361","author":"P Jara","year":"2009","unstructured":"Jara P, Hierro L, Martinez-Fernandez P. Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med. 2009;361:1359\u201367.","journal-title":"N Engl J Med"},{"key":"1365_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12016-014-8457-4","volume":"48","author":"R Kubitz","year":"2015","unstructured":"Kubitz R, Dr\u00f6ge C, Kluge S, Stross C, Walter N, Keitel V, et al. Autoimmune BSEP disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis. Clin Rev Allergy Immunol. 2015;48:273\u201384.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1365_CR26","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1016\/j.transproceed.2016.02.067","volume":"48","author":"K Masahata","year":"2016","unstructured":"Masahata K, Uehara S, Ibuka S, Nakahata K, Hasegawa Y, Kondou H, et al. Recurrence of progressive familial intrahepatic cholestasis type 2 phenotype after living-donor liver transplantation: a case report. Transplant Proc. 2016;48:3156\u201362.","journal-title":"Transplant Proc"},{"key":"1365_CR27","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1016\/j.transproceed.2003.10.047","volume":"35","author":"A Bassas","year":"2003","unstructured":"Bassas A, Chehab M, Hebby H, Al Shahed M, Al Husseini H, Al Zahrani A, et al. Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. Transplant Proc. 2003;35:3003\u20135.","journal-title":"Transplant Proc"},{"key":"1365_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MPG.0b013e3181f50363","volume":"52","author":"C Colombo","year":"2011","unstructured":"Colombo C, Vajro P, Degiorgio D, Coviello DA, Costantino L, Tornillo L, et al. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type-3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr. 2011;52:73\u201383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1365_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12098-011-0516-8","volume":"79","author":"S Kaur","year":"2012","unstructured":"Kaur S, Sharma D, Wadhwa N, Gupta S, Chowdhary SK, Sibal A. Therapeutic interventions in progressive familial intrahepatic cholestasis: experience from a tertiary care centre in north India. Indian J Pediatr. 2012;79:270\u20133.","journal-title":"Indian J Pediatr"},{"key":"1365_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jceh.2016.05.003","volume":"6","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Lal BB, Rawat D, Rastogi A, Bharathy KG, Alam S. Progressive familial intrahepatic cholestasis (PFIC) in Indian children: clinical spectrum and outcome. J Clin Exp Hepatol. 2016;6:203\u20138.","journal-title":"J Clin Exp Hepatol"},{"key":"1365_CR31","doi-asserted-by":"publisher","first-page":"666","DOI":"10.12659\/AOT.909941","volume":"23","author":"Y Liu","year":"2018","unstructured":"Liu Y, Sun LY, Zhu ZJ, Wei L, Qu W, Zeng ZG. Liver transplantation for progressive familial intrahepatic cholestasis. Ann Transplant. 2018;23:666\u201373.","journal-title":"Ann Transplant"},{"key":"1365_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ebiom.2017.10.007","volume":"27","author":"H Hayashi","year":"2018","unstructured":"Hayashi H, Naoi S, Togawa T, Hirose Y, Kondou H, Hasegawa Y, et al. Assessment of ATP8B1 deficiency in pediatric patients with cholestasis using peripheral blood monocyte-derived macrophages. EBioMedicine. 2018;27:187\u201399.","journal-title":"EBioMedicine"},{"key":"1365_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jpedsurg.2011.08.010","volume":"47","author":"N Schukfeh","year":"2012","unstructured":"Schukfeh N, Metzelder ML, Petersen C, Reismann M, Pfister ED, Ure BM, et al. Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis. J Pediatr Surg. 2012;47:501\u20135.","journal-title":"J Pediatr Surg"},{"key":"1365_CR34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/petr.12782","volume":"20","author":"VP Mali","year":"2016","unstructured":"Mali VP, Fukuda A, Shigeta T, Uchida H, Hirata Y, Rahayatri TH, et al. Total internal biliary diversion during liver transplantation for type 1 progressive familial intrahepatic cholestasis: a novel approach. Pediatr Transplant. 2016;20:981\u20136.","journal-title":"Pediatr Transplant"},{"key":"1365_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1053\/jlts.2002.34384","volume":"8","author":"H Egawa","year":"2002","unstructured":"Egawa H, Yorifuji T, Sumazaki R, Kimura A, Hasegawa M, Tanaka K. Intractable diarrhea after liver transplantation for Byler\u2019s disease: successful treatment with bile adsorptive resin. Liver Transplant. 2002;8:714\u20136.","journal-title":"Liver Transplant"},{"key":"1365_CR36","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0016-5085(99)70287-8","volume":"117","author":"PL Jansen","year":"1999","unstructured":"Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, et al. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology. 1999;117:1370\u20139.","journal-title":"Gastroenterology"},{"key":"1365_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/j.1600-6143.2008.02440.x","volume":"8","author":"CE Freise","year":"2008","unstructured":"Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant. 2008;8:2569\u201379.","journal-title":"Am J Transplant"},{"key":"1365_CR38","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/lt.23956","volume":"20","author":"RS Hoehn","year":"2014","unstructured":"Hoehn RS, Wilson GC, Wima K, Hohmann SF, Midura EF, Woodle ES, et al. Comparing living donor and deceased donor liver transplantation: a matched national analysis from 2007 to 2012. Liver Transplant. 2014;20:1347\u201355.","journal-title":"Liver Transplant"},{"key":"1365_CR39","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/hep.27872","volume":"62","author":"S Zhou","year":"2015","unstructured":"Zhou S, Hertel PM, Finegold MJ, Wang L, Kerkar N, Wang J, et al. Hepatocellular carcinoma associated with tight-junction protein 2 deficiency. Hepatology. 2015;62:1914\u20136.","journal-title":"Hepatology"},{"key":"1365_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0030-1253223","volume":"30","author":"A Davit-Spraul","year":"2010","unstructured":"Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis. 2010;30:134\u201346.","journal-title":"Semin Liver Dis"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01365-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01365-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T06:15:47Z","timestamp":1642054547000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01365-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01365-1","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2000) and approved by the institutional research board (no. 18459-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patients for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}